Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal Cancer

Exclusion Criteria

• •Patients receiving systemic steroids in the two months prior to study entry.
• •Patients taking concomitant warfarin or other blood thinners.
• •Known or suspected hypersensitivity to eicosapentaenoic acid/omega 3.
• •Women who are pregnant or of childbearing age who do not accept the use of contraceptive methods specified in the study (oral contraception, IUDs) and breastfeeding women.
• •Patients with severe medical conditions that, in the opinion of the investigator, contraindicate the patient's participation in the study.
• •Changes of treatments and / or use of experimental drugs within 3 months before inclusion in the study.
• •Use of Probiotics
• •Arm: no intervention
• •HBV-positive, HCV-positive, HIV-positive or otherwise affected by infectious diseases
• •Subjects undergoing chemo and radiation therapy within six months prior to surgery
• •Patients receiving systemic steroid in the two months prior to study entry
• •Patients undergoing antibiotic therapy within three months prior to the study
• •Patients treated with probiotics